The pharmaceutical field is seeing a major shift in blood sugar care with the emergence of GLP-1 patches. These groundbreaking delivery systems offer a likely simple choice to injections for individuals dealing with diabetes mellitus type 2. By avoiding the need for frequent needles, GLP-1 skin devices promise to boost user compliance and general l